Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax, Ixazomib, and Dexamethasone in Relapsed Multiple Myeloma
NCT03399539Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- May 2018
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial of venetoclax in multiple myeloma (MM), sponsored by Mayo Clinic. Started May 2018; status: completed.
02
Drugs
venetoclax
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03399539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03399539.